4.8 Article

Mussel-inspired catalytic selenocystamine-dopamine coatings for long-term generation of therapeutic gas on cardiovascular stents

Journal

BIOMATERIALS
Volume 178, Issue -, Pages 1-10

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.biomaterials.2018.06.008

Keywords

Nitric oxide; Selenocystamine; Dopamine; Cardiovascular stent; Surface chemistry

Funding

  1. National Natural Science Foundation of China [31570957, 81501596, 81330031]
  2. Distinguished Young Scholars of Sichuan Province [2016JQ0027]
  3. Fundamental Research Funds for the Central Universities [2682018ZT23]
  4. start-up fund from the Hong Kong Polytechnic University [1-ZE7S]
  5. central research fund (G-YBWS) from the Hong Kong Polytechnic University

Ask authors/readers for more resources

The development of a nitric oxide (NO)-generating surface with long-term, stable and controllable NO release improves the therapeutic efficacy of cardiovascular stents. In this work, we developed a one-pot method inspired by mussel adhesive proteins for copolymerization of selenocystamine (SeCA) and dopamine (Dopa) to form a NO-generating coating on a 316 L stainless steel (SS) stent. This one-pot method is environmentally friendly and easy to popularize, with many advantages including simple manufacturing procedure, high stability and no involvement of organic solvents. Such SeCA/Dopa coatings also enabled us to develop a catalytic surface for local NO-generation by reaction of endogenously existing S-nitrothiol species from fresh blood. We found that the developed SeCA/Dopa coatings could release NO in a controllable and stable manner for more than 60 days. Additionally, the released NO significantly inhibited smooth muscle cell (SMC) proliferation and migration, as well as platelet activation and aggregation through the up-regulation of cyclic guanosine monophosphate synthesis. Moreover, such NO generation enhanced the adhesion, proliferation and migration of endothelial cells (ECs), and achieved rapid in vivo re-endothelialization, effectively reducing in-stent restenosis and neointimal hyperplasia. We envision that the SeCA/Dopa-coated 316L SS stent could be a promising platform for treatment of cardiovascular diseases. (C) 2018 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available